We are a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19.
$15.00 - $18.00
February 10, 2021
H.C. WAINWRIGHT & CO., INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Biophytis SA IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277